Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
63,276,056
-
Share change
-
-6,226,912
-
Total reported value
-
$1,021,904,242
-
Put/Call ratio
-
14%
-
Price per share
-
$16.15
-
Number of holders
-
100
-
Value change
-
-$89,834,807
-
Number of buys
-
45
-
Number of sells
-
41
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2017
As of 30 Sep 2017,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,276,056 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, FMR LLC, JANUS HENDERSON GROUP PLC, Broadfin Capital, LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., and CARLSON CAPITAL L P.
This page lists
100
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.